2m 2m 2m 2m 2m 2m 2m
ALTO NEURO (ANRO)
NYSE
$24.35-$0.09 (-0.36%)
Price as of Jun 23, 2026 7:57 PM EDT- $804.7MMarket Cap
- 877.60%1-Year Change
- BiotechnologyIndustry
ALTO NEURO (ANRO)
$24.35-$0.09 (-0.36%)
ANRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.44 | ||
Change | +$1.51 (+6.59%) | ||
Open | $22.32 | ||
High | $25.80 | ||
Low | $22.32 | ||
Previous Close | $22.93 | ||
Volume | 404,615 | ||
30-Day Average Volume | 348,217 | ||
1-Week Change | 16.38% | ||
1-Month Change | 15.17% | ||
1-Year Change | 877.60% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 35.1M | ||
Total Assets | $276.3M | ||
Market Cap | $804.7M | ||
Enterprise Value | $559.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$26.2M | ||
Free Cash Flow | -$27.6M | ||
EBIT | -$25.7M | ||
EBITDA | -$25.6M | ||
Net Working Capital | $256.0M | ||
EPS | -$0.80 | ||
Enterprise Value/EBITDA | -22 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -29 | ||
PEG | 0 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue